Cudarolimab (Anti-TNFRSF4 / OX40 / CD134)
Cudarolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4, TNFRSF4, CD134, OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. MW : 145.94 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2814 |
| Sku # | A2814-1mg*5 |
| Pricing | 1mg*5, $970.00 |